LEADER 04759nam 2201153z- 450 001 9910639987603321 005 20231214133515.0 010 $a3-0365-5824-1 035 $a(CKB)5470000001633478 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/95862 035 $a(EXLCZ)995470000001633478 100 $a20202301d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aScreening and Treatment of Perinatal Depression and Anxiety 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (208 p.) 311 $a3-0365-5823-3 330 $aThis reprint focuses on the assessment, screening and intervention of perinatal depression and anxiety, which have been internationally recognized as relevant mental health problems affecting the whole family system. The contents are of interest for all professionals working in the field of perinatal mental health. Special attention in the reprint is given to three main domains: clinical characteristics of perinatal depression and anxiety in women and men; psychometric properties and usefulness of screening tools; and types of intervention. The first area focuses on the investigation of prevalence, risk factors and predictors of perinatal depression and anxiety, considering different samples of women and/or men, during the prenatal and postpartum period; a glance is also given to perinatal mental health difficulties experienced during the COVID-19 pandemic. The second area is focused on the description of psychometric properties of tools for the detection and screening of perinatal anxiety and depression. This section includes contributions regarding: comparisons among different tools, further validation of already existing questionnaires and validation of new instruments, which could enhance the early detection of depressive and anxiety symptoms. The third area focuses on different approaches of intervention to reduce perinatal depression and anxiety, including gender-transformative interventions to address perinatal mental health and clinical guidelines for the pharmacological management of both depression and anxiety. 606 $aPsychology$2bicssc 610 $aEdinburgh Postnatal Depression Scale (EPDS) 610 $aSlovakia 610 $avalidity 610 $apostpartum depression 610 $apregnancy 610 $aCOVID-19 610 $apandemic stress 610 $acorrelates of stress 610 $ainfection 610 $apreparedness 610 $aInsomnia Symptom Questionnaire 610 $asleep disorders 610 $aperinatal period 610 $ainternal consistency 610 $aconvergent validity 610 $apredictors 610 $alongitudinal study 610 $aanxiety 610 $achildbirth experience 610 $aclinical practice guideline 610 $adepression 610 $aantidepressant 610 $apsychotropic medications 610 $aperipartum 610 $achildbirth 610 $afear 610 $aassessment 610 $abirth 610 $aquestionnaire development 610 $acaesarean 610 $avaginal 610 $achildbirth anxiety 610 $aanxiety in pregnancy 610 $aSARS-CoV-2 610 $apandemic 610 $asupport 610 $aperinatal care 610 $achildbirth school 610 $aperinatal 610 $ascreening 610 $avalidation 610 $aEPDS 610 $aperinatal mental health 610 $aanxiety disorders 610 $aperinatal anxiety 610 $afear of childbirth 610 $apostnatal 610 $aidentifying 610 $aGAD 610 $aquestionnaires 610 $astructural validity 610 $aperinatal depression 610 $aresponsiveness 610 $aonline and offline intervention 610 $apostpartum women 610 $ae-health technology 610 $asocial stigma 610 $asocial support 610 $astudy protocol 610 $afathers 610 $apreterm birth 610 $aseverity of prematurity 610 $aELBW 610 $aVLBW 610 $aparenting stress 610 $apartner?s influence 610 $agender transformative interventions 610 $ascoping review 610 $aLMIC 615 7$aPsychology 700 $aAgostini$b Francesca$4edt$01279881 702 $aAgostini$b Francesca$4oth 906 $aBOOK 912 $a9910639987603321 996 $aScreening and Treatment of Perinatal Depression and Anxiety$93016106 997 $aUNINA